VANCOUVER, Oct. 17 /PRNewswire/ - iCo Therapeutics Inc. announced today
that Andrew Rae, iCo's Chief Executive Officer, will present at the BIO
InvestorForum to be held October 19-20th, 2005 in San Francisco, California.
Approximately 190 public and venture-stage companies are slated to present at
this conference which is being hosted by the Biotechnology Industry
Mr. Rae's presentation will take place on October 20th, 2005 at
12:20pm PST in the Sea Cliff room at the Palace Hotel in San Francisco. For
more information about the conference, visit the BIO InvestorForum website at
A live audio webcast of Mr. Rae's presentation will be available to all
interested parties through a link posted on iCo's website at
iCo seeks out and develops or modifies approved or near-approved
therapies to treat a variety of conditions within isolated biological
environments. Because the drugs have already been through extensive
preclinical and clinical testing, and in some cases regulatory approval,
development risk and time to commercialization is significantly decreased.
iCo Therapeutics Inc. is an emerging, Vancouver-based biotechnology
company focused on developing pre-existing drugs for a range of new conditions
affecting isolated biological environments - areas such as the eye, spinal
cord, or joints - where locally-administered application of these therapies
would have minimal systemic distribution and fewer safety issues.
For more information, visit the company website at:
Business Development Contact: Finance/Investor Contact:
Dr. John Clement, CTO Mr. John Meekison, CFO
Elayne Wandler, ABCommunications
SOURCE iCo Therapeutics Inc.